New CAR T Therapy Method
This is a news story, published by MSN, that relates primarily to Medical Research Institute news.
biology news
For more biology news, you can click here:
more biology newsMSN news
For more news from MSN, you can click here:
more news from MSNAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
gene therapy products. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Molecular Therapy news, new viral vectors news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Chimeric antigen receptorMedical Xpress - medical research advances and health news
•Science
Science
Proof-of-concept study bioengineers therapeutics for improved cancer treatment
79% Informative
Children's Medical Research Institute scientists have identified a new method for producing a therapeutic product that has the potential to improve the treatment of cancer.
Chimeric antigen receptor ( CAR ) T cells, also known as CAR T therapies, are a relatively new form of treatment showing very exciting results for several types of cancer, including solid tumors.